Article
Fitness trade-offs restrict the evolution of resistance to amphotericin B.
PLoS biology - 1 Oct 2013
Vincent Benjamin Matteson, Lancaster Alex Kelvin, Scherz-Shouval Ruth, Whitesell Luke, Lindquist Susan
Abstract excerpt
The evolution of drug resistance in microbial pathogens provides a paradigm for investigating evolutionary dynamics with important consequences for human health. Candida albicans, the leading fungal pathogen of humans, rapidly evolves resistance to two major antifungal classes, the triazoles and echinocandins. In contrast, resistance to the third major antifungal used in the clinic, amphotericin B (AmB), remains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
